Analysts Set Willis Towers Watson PLC (WLTW) Target Price at $173.54
Willis Towers Watson PLC (NASDAQ:WLTW) has received a consensus rating of “Hold” from the nineteen research firms that are presently covering the company, Marketbeat.com reports. Three analysts have rated the stock with a sell rating, five have assigned a hold rating, ten have assigned a buy rating and one has issued a strong buy rating on the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $174.00.
WLTW has been the subject of several recent research reports. Credit Suisse Group upgraded Willis Towers Watson from a “neutral” rating to an “outperform” rating and set a $166.00 price target for the company in a research report on Monday, October 8th. Citigroup set a $165.00 price objective on Willis Towers Watson and gave the company a “buy” rating in a research note on Friday, October 12th. BidaskClub lowered Willis Towers Watson from a “hold” rating to a “sell” rating in a research note on Thursday, September 27th. Morgan Stanley dropped their price objective on Willis Towers Watson from $175.00 to $171.00 and set an “overweight” rating for the company in a research note on Friday, August 3rd. Finally, Zacks Investment Research lowered Willis Towers Watson from a “hold” rating to a “sell” rating in a research note on Wednesday, August 8th.
Shares of NASDAQ WLTW opened at $160.26 on Friday. The firm has a market capitalization of $20.64 billion, a PE ratio of 18.83, a P/E/G ratio of 1.36 and a beta of 0.74. Willis Towers Watson has a fifty-two week low of $134.50 and a fifty-two week high of $164.99. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.86 and a quick ratio of 1.86.
In other Willis Towers Watson news, insider Julie Jarecke Gebauer sold 10,000 shares of Willis Towers Watson stock in a transaction dated Tuesday, November 13th. The stock was sold at an average price of $160.15, for a total transaction of $1,601,500.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Adam Garrard sold 1,830 shares of Willis Towers Watson stock in a transaction dated Friday, August 31st. The stock was sold at an average price of $146.77, for a total value of $268,589.10. Following the sale, the insider now directly owns 13,739 shares of the company’s stock, valued at approximately $2,016,473.03. The disclosure for this sale can be found here. Insiders have sold 14,280 shares of company stock valued at $2,251,211 in the last three months. 0.50% of the stock is owned by corporate insiders.
A number of hedge funds have recently modified their holdings of the business. Allianz Asset Management GmbH grew its position in Willis Towers Watson by 5.3% in the 1st quarter. Allianz Asset Management GmbH now owns 42,543 shares of the financial services provider’s stock valued at $6,475,000 after buying an additional 2,127 shares in the last quarter. Atria Investments LLC bought a new position in Willis Towers Watson in the 2nd quarter valued at about $238,000. Municipal Employees Retirement System of Michigan grew its position in Willis Towers Watson by 202.9% in the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 10,510 shares of the financial services provider’s stock valued at $1,593,000 after buying an additional 7,040 shares in the last quarter. Exane Derivatives bought a new position in Willis Towers Watson in the 2nd quarter valued at about $214,000. Finally, Cornerstone Wealth Management LLC bought a new position in Willis Towers Watson in the 2nd quarter valued at about $103,000. 91.78% of the stock is owned by hedge funds and other institutional investors.
Willis Towers Watson Company Profile
Willis Towers Watson Public Limited Company operates as an advisory, broking, and solutions company worldwide. Its Human Capital and Benefits segment provides actuarial support, plan design, and administrative services for traditional pension and retirement savings plans; plan management consulting, broking, and administration services for health and group benefit programs; and benefits outsourcing services.
Read More: How Do I Invest in Dividend Stocks
Receive News & Ratings for Willis Towers Watson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Willis Towers Watson and related companies with MarketBeat.com's FREE daily email newsletter.